Prognostic Value of the Syntax Score in Patients Undergoing Coronary Artery Bypass Grafting for Three-Vessel Coronary Artery Disease

被引:50
作者
Lemesle, Gilles [1 ]
Bonello, Laurent [1 ]
de Labriolle, Axel [1 ]
Steinberg, Daniel H. [1 ]
Roy, Probal [1 ]
Slottow, Tina L. Pinto [1 ]
Torguson, Rebecca [1 ]
Kaneshige, Kimberly [1 ]
Xue, Zhenyi [1 ]
Suddath, William O. [1 ]
Satler, Lowell F. [1 ]
Kent, Kenneth M. [1 ]
Lindsay, Joseph [1 ]
Pichard, Augusto D. [1 ]
Waksman, Ron [1 ]
机构
[1] Washington Hosp Ctr, Div Cardiol, Washington, DC 20010 USA
关键词
cardiac catheterization/intervention; coronary artery bypass grafts; outcomes; stents; SIROLIMUS-ELUTING STENT; RANDOMIZED-TRIAL; REVASCULARIZATION THERAPIES; MULTIVESSEL DISEASE; ANGIOPLASTY; SURGERY; MORTALITY; RISK; METAANALYSIS; PREDICTORS;
D O I
10.1002/ccd.21883
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Syntax score prognostic value has recently been highlighted in patients undergoing percutaneous coronary intervention (PCI) for multivessel coronary artery disease (CAD), however its prognostic value in patients undergoing coronary artery bypass grafting (CABG) for multivessel CAD is still unknown. The aim of this study was to evaluate the prognostic value of the Syntax score in patients undergoing CABG for 3-vessel CAD. Methods: A cohort of 320 consecutive patients with multivessel (3-vessel) CAD who were subjected for CABG were included in this study and divided into tertiles according to the Syntax score (<24.5, 24.5-34, and >34). During the 1-year follow-up, cardiovascular events including death, myocardial infarction (MI), and stroke were systematically indexed. The primary end point was the composite criteria death/MI/stroke. Results: The Syntax score ranged from 11-74 with a mean of 31.2 +/- 12.6 and a median of 28.5 [22-38]. Baseline clinical characteristics were similar among the tertiles. No statistical difference was found for the composite criteria death/MI/stroke: 9.4% versus 7.5% versus 10.4% in the groups with a Syntax score <24.5, 24.5-34, and >34, respectively (P = 0.754). Conclusion: Unlike for PCI, the Syntax score has a poor prognostic value for severe cardiovascular events in patients undergoing CABG for 3-vessel CAD. Other risk scores should be used to predict the outcome of this population. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:612 / 617
页数:6
相关论文
共 35 条
  • [1] Alderman EL, 1996, NEW ENGL J MED, V335, P217
  • [2] [Anonymous], 1995, Lancet, V346, P1179
  • [3] Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery
    Boodhwani, Munir
    Rubens, Fraser D.
    Wozny, Denise
    Rodriguez, Rosendo
    Alsefaou, Abdualla
    Hendry, Paul J.
    Nathan, Howard J.
    [J]. CIRCULATION, 2006, 114 : I461 - I466
  • [4] Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry
    Brooks, MM
    Jones, RH
    Bach, RG
    Chaitman, BR
    Kern, MJ
    Orszulak, TA
    Follmann, D
    Sopko, G
    Blackstone, EH
    Califf, RM
    [J]. CIRCULATION, 2000, 101 (23) : 2682 - 2689
  • [5] Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
    Colombo, A
    Drzewiecki, J
    Banning, A
    Grube, E
    Hauptmann, K
    Silber, S
    Dudek, D
    Fort, S
    Schiele, F
    Zmudka, K
    Guagliumi, G
    Russell, ME
    [J]. CIRCULATION, 2003, 108 (07) : 788 - 794
  • [6] Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS)
    Costa, MA
    Carere, RG
    Lichtenstein, SV
    Foley, DP
    de Valk, V
    Lindenboom, W
    Roose, PCH
    van Geldorp, TR
    Macaya, C
    Castanon, JL
    Fernandez-Avilèz, F
    Herreros, J
    Heyer, G
    Unger, F
    Serruys, PW
    [J]. CIRCULATION, 2001, 104 (22) : 2689 - 2693
  • [7] A RANDOMIZED STUDY OF CORONARY ANGIOPLASTY COMPARED WITH BYPASS-SURGERY IN PATIENTS WITH SYMPTOMATIC MULTIVESSEL CORONARY-DISEASE
    HAMM, CW
    REIMERS, J
    ISCHINGER, T
    RUPPRECHT, HJ
    BERGER, J
    BLEIFELD, W
    ENGELSTEIN, E
    SCHUCHERT, A
    CORTES, A
    FRANKE, C
    KUCK, KH
    TERRES, W
    MEINERTZ, T
    KALMAR, P
    KREBBER, H
    DARUP, J
    DIETZ, U
    MEYER, J
    ERBEL, R
    OELERT, H
    TRAUTMANN, S
    IVERSEN, S
    DELIUS, W
    RIESS, G
    ANTONI, D
    HACKER, R
    MEUDT, M
    VOELKER, W
    KARSCH, K
    SEIPEL, L
    SCHANZENBACHER, P
    KOCHSIEK, K
    UEBIS, R
    SIGMUND, M
    HANRATH, P
    SCHMITT, H
    NEUHAUS, KL
    SUPPLIETH, M
    LUNSTEDT, G
    WENDEROTH, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (16) : 1037 - 1043
  • [8] HAMPTON JR, 1993, LANCET, V341, P573
  • [9] Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease
    Hannan, Edward L.
    Wu, Chuntao
    Walford, Gary
    Culliford, Alfred T.
    Gold, Jeffrey P.
    Smith, Craig R.
    Higgins, Robert S. D.
    Carlson, Russell E.
    Jones, Robert H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (04) : 331 - 341
  • [10] Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting - Renal function and mortality after 3.8 years
    Hillis, Graham S.
    Zehr, Kenton J.
    Williams, Amy W.
    Schaff, Hartzell V.
    Orzulak, Thomas A.
    Daly, Richard C.
    Mullany, Charles J.
    Rodeheffer, Richard J.
    Oh, Jae K.
    [J]. CIRCULATION, 2006, 114 : I414 - I419